What is the Reason That the Pharmacological Future of Chemotherapeutics in the Treatment of Lung Cancer Could Be Most Closely Related to Nanostructures? Platinum Drugs in Therapy of Non-Small and Small Cell Lung Cancer and Their Unexpected, Possible Interactions. The Review

Kamil Szupryczyński,1 Przemysław Czeleń,2 Tomasz Jeliński,2 Beata Szefler2 1Doctoral School of Medical and Health Sciences, Faculty of Pharmacy, Collegium Medicum, Nicolaus, Copernicus University, Bydgoszcz, Poland; 2Department of Physical Chemistry, Facul...

Full description

Bibliographic Details
Published in:International Journal of Nanomedicine
Main Authors: Szupryczyński K, Czeleń P, Jeliński T, Szefler B
Format: Article
Language:English
Published: Dove Medical Press 2024-09-01
Subjects:
fullerenes
nanotube
nanoparticles
drug delivery
personalized medicine
platinum-based drugs
cisplatin
carboplatin
oxaliplatin
nedaplatin
heptaplatin
lobaplatin
cancer treatment
vitamin b
thiamine (b1)
pyridoxal phosphate (b6)
niacin (b3)
riboflavin (b2).
Online Access:https://www.dovepress.com/what-is-the-reason-that-the-pharmacological-future-of-chemotherapeutic-peer-reviewed-fulltext-article-IJN

Internet

https://www.dovepress.com/what-is-the-reason-that-the-pharmacological-future-of-chemotherapeutic-peer-reviewed-fulltext-article-IJN

Similar Items